Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 36 | 12 | 12 | 4 |
| Cost of Goods | N/A | 23 | 8 | 8 | 1 |
| Gross Profit | N/A | 13 | 4 | 4 | 3 |
| Operating Expenses | 8,230 | 1,312 | 1,908 | 1,584 | 1,828 |
| Operating Income | -8,230 | -1,276 | -1,897 | -1,572 | -1,824 |
| Interest Expense | 7 | 3 | 7 | 33 | 32 |
| Other Income | 0 | 0 | -5 | -220 | -215 |
| Pre-tax Income | -8,236 | -1,279 | -1,909 | -1,825 | -2,071 |
| Net Income Continuous | -8,236 | -1,279 | -1,909 | -1,825 | -2,071 |
| Net Income | $-8,236 | $-1,279 | $-1,909 | $-1,825 | $-2,071 |
| EPS Basic Total Ops | -2.78 | -0.47 | -0.97 | -1.05 | -1.32 |
| EPS Basic Continuous Ops | -2.78 | -0.47 | -0.98 | -1.05 | -1.32 |
| EPS Diluted Total Ops | -2.78 | -0.47 | -0.97 | -1.05 | -1.32 |
| EPS Diluted Continuous Ops | -2.78 | -0.47 | -0.98 | -1.05 | -1.32 |
| EPS Diluted Before Non-Recurring Items | -2.78 | -0.47 | -0.96 | N/A | N/A |
| EBITDA(a) | $-8,204 | $-1,251 | $-1,945 | $-1,519 | $-1,896 |